BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,116 | +630.6% | 397,398 | +818.0% | 0.13% | +318.8% |
| Q4 2022 | $2,206 | -99.9% | 43,290 | +67.7% | 0.03% | +60.0% |
| Q2 2022 | $1,658,000 | -81.8% | 25,807 | -78.0% | 0.02% | -82.6% |
| Q1 2022 | $9,116,000 | -17.1% | 117,571 | -13.9% | 0.12% | -5.7% |
| Q2 2021 | $10,998,000 | +988.9% | 136,625 | +1040.7% | 0.12% | +713.3% |
| Q1 2021 | $1,010,000 | -83.1% | 11,977 | -83.9% | 0.02% | -74.1% |
| Q4 2020 | $5,973,000 | -69.1% | 74,442 | -69.1% | 0.06% | -84.9% |
| Q3 2020 | $19,351,000 | +1190.1% | 240,625 | +1281.6% | 0.38% | +887.2% |
| Q2 2020 | $1,500,000 | -51.7% | 17,417 | -54.5% | 0.04% | -77.2% |
| Q1 2020 | $3,108,000 | +410.3% | 38,286 | +449.5% | 0.17% | +714.3% |
| Q3 2019 | $609,000 | -85.9% | 6,968 | -86.8% | 0.02% | -87.8% |
| Q2 2019 | $4,325,000 | +6.5% | 52,812 | +5.8% | 0.17% | -43.0% |
| Q1 2019 | $4,060,000 | +46.1% | 49,928 | +18.3% | 0.30% | +54.1% |
| Q4 2018 | $2,778,000 | – | 42,205 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |